Arrowhead Pharmaceuticals, Inc. (ARWR)

Last Closing Price: 64.66 (2025-12-04)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Arrowhead Pharmaceuticals, Inc. (ARWR) had Net Income of $-23.75M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$256.47M
Net Income
$-23.75M
--
$256.47M
$212.37M
$44.11M
$-7.99M
$36.12M
$36.12M
$16.12M
$16.12M
$16.12M
$16.12M
$44.11M
$49.25M
133.76M
133.76M
$-0.14
$-0.11
Balance Sheet Financials
$950.64M
$382.51M
$434.66M
$1.39B
$195.49M
$214.88M
$686.39M
$881.88M
$503.42M
$496.56M
$503.42M
135.70M
Cash Flow Statement Financials
$179.55M
$-129.29M
$74.01M
$102.69M
$226.55M
$123.86M
$63.37M
--
--
Fundamental Metrics & Ratios
4.86
--
--
0.30
0.51
100.00%
17.20%
17.20%
--
14.08%
-9.26%
$156.89M
--
--
--
0.19
--
37.58
2.39
3.20%
3.25%
1.16%
2.24%
$3.71
$1.17
$1.34